世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037057

抗肥満薬の世界市場レポート(2024年)

The Business Research Company

Antiobesity Global Market Report 2024

発刊日 2023/11/28

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000037057

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、抗肥満薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている抗肥満薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤クラス別
      ◇ 末梢的に作用する抗肥満薬
      ◇ 中枢性抗肥満薬
    ➣ タイプ別
      ◇ 処方薬(Rx)
      ◇ OTC(市販薬)
    ➣ 投薬別
      ◇ 単独療法
      ◇ 複合療法
  • 調査企業
    ➣ F. Hoffmann-La Roche AG
    ➣ GlaxoSmithKline plc
    ➣ Boehringer Ingelheim GmbH
    ➣ Pfizer Inc.
    ➣ Merck & Co. Inc.
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Antiobesity Market Characteristics

3. Antiobesity Market Trends And Strategies

4. Antiobesity Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Antiobesity Market Size and Growth
5.1. Global Antiobesity Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Antiobesity Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Antiobesity Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antiobesity Market Segmentation
6.1. Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Drugs (Rx)
OTC (over the counter) Drugs
6.2. Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Peripherally Acting Anti Obesity Drugs
Centrally Acting Anti Obesity Drugs
6.3. Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Monotherapies
Polytherapies

7. Antiobesity Market Regional And Country Analysis
7.1. Global Antiobesity Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Antiobesity Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antiobesity Market
8.1. Asia-Pacific Antiobesity Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antiobesity Market
9.1. China Antiobesity Market Overview
9.2. China Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antiobesity Market
10.1. India Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antiobesity Market
11.1. Japan Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antiobesity Market
12.1. Australia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antiobesity Market
13.1. Indonesia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antiobesity Market
14.1. South Korea Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antiobesity Market
15.1. Western Europe Antiobesity Market Overview
15.2. Western Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antiobesity Market
16.1. UK Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antiobesity Market
17.1. Germany Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antiobesity Market
18.5. France Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antiobesity Market
19.9. Italy Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antiobesity Market
20.13. Spain Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antiobesity Market
21.1. Eastern Europe Antiobesity Market Overview
21.2. Eastern Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antiobesity Market
22.1. Russia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antiobesity Market
23.1. North America Antiobesity Market Overview
23.2. North America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antiobesity Market
24.1. USA Antiobesity Market Overview
24.2. USA Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antiobesity Market
25.1. Canada Antiobesity Market Overview
25.2. Canada Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antiobesity Market
26.1. South America Antiobesity Market Overview
26.2. South America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antiobesity Market
27.1. Brazil Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antiobesity Market
28.1. Middle East Antiobesity Market Overview
28.2. Middle East Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antiobesity Market
29.1. Africa Antiobesity Market Overview
29.2. Africa Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antiobesity Market Competitive Landscape And Company Profiles
30.1. Antiobesity Market Competitive Landscape
30.2. Antiobesity Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. GlaxoSmithKline plc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Boehringer Ingelheim GmbH
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Pfizer Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Merck & Co. Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Global Antiobesity Market Competitive Benchmarking

32. Global Antiobesity Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Antiobesity Market

34. Antiobesity Market Future Outlook and Potential Analysis
34.1 Antiobesity Market In 2028 - Countries Offering Most New Opportunities
34.2 Antiobesity Market In 2028 - Segments Offering Most New Opportunities
34.3 Antiobesity Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

この商品のレポートナンバー

0000037057

TOP